Clinical Trial Update: O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating O6-Benzylguanine with Carmustine implants for recurrent malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Carmustine (carmustine)
• O6-Benzylguanine (O6-Benzylguanine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED